OR WAIT null SECS
August 01, 2018
API can be mixed with silicone and other polymers to create drug-delivery combination products.
This article provides a sampling of the latest investments, expansions, and acquisitions by small-molecule contract service providers.
Heightened uncertainty means CDMO executives need to play out planning scenarios.
Real-life examples illustrate how to reduce the risks for each transferring partner and ensure that the development process meets regulatory requirements.
July 24, 2018
The glass and chemical provider will expand its synthetic pharmaceutical intermediate and API production capacity at its plant in Chiba, Japan.
July 23, 2018
The acquisition will place Cambrex into the finished dosage form CDMO market.
July 02, 2018
This article highlights 15 years of changes in biopharmaceutical manufacturing.
Vendors are offering template-based models and direct data-filing services to help smaller companies meet imminent deadlines.
May 17, 2018
Vetter's FOYA award-winning facility is an example of a flexible pharmaceutical and biopharmaceutical modular facility design that allows expansion of space without affecting existing operations.
May 03, 2018
The company has begun expansion efforts for its process-development capabilities and laboratory infrastructure.